Global /China /Healthcare /Drug Manufacturers - General /300573

Shenyang Xingqi Pharmaceutical Co.,Ltd.

300573

• SHE: 300573 • Delayed

69.45CNY -1.3%

10.26 USD

As of 16 June 2026, Shenyang Xingqi Pharmaceutical Co.,Ltd. has a market cap of $2.56B USD, ranking #6035 globally and #1360 in China. It ranks #477 in the Healthcare sector, and #187 in the Drug Manufacturers - General industry.

Global Rank

6035

Country Rank

1360

Sector Rank

477

Industry Rank

187

Key Stats

Market Cap

$2.56BUSD

17.34B CNY

Enterprise Value

$2.49BUSD

16.85B CNY

Revenue (TTM)

$386.93MUSD

2.62B CNY

EBITDA (TTM)

$141.44MUSD

957.19M CNY

Net Income (TTM)

$111.7MUSD

756.37M CNY

EBITDA Margin

37%

Profit Margin

29%

PE Ratio

22.8

PS Ratio

6.6

PB Ratio

7.9

EV/EBITDA

17.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

E. Gao open_in_new

Employees

2,396

Founded

1977

Website

sinqi.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.3%	2.4%	5.5%	-2.3%	-15%	-0.7%	19%	9.4%	38%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300573 沈阳兴齐眼药股份有限公司 Class A ISIN: CNE100002DV1 Shares Out.: Shares Outstanding: 357.323M¹ Shares Float: 355.71M² TV: TradingView: SZSE: 300573 SA: Stock Analysis: SHE: 300573 YF: Yahoo Finance: 300573.SZ GF: Google Finance: SHE: 300573 BA: Barron's: 300573 MS: Morningstar: XSHE: 300573	69.45 CNY	TV: TradingView: SZSE: 300573 SA: Stock Analysis: SHE: 300573 YF: Yahoo Finance: 300573.SZ GF: Google Finance: SHE: 300573 BA: Barron's: 300573 MS: Morningstar: XSHE: 300573

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shenyang Xingqi Pharmaceutical Co.,Ltd.

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicines, mydriatics and cycloplegia drugs, miotics and anti-glaucoma drugs, and intraoperative intraocular irrigation fluids. It also engages in technology development, technical advice, eye hospital, and research and experimental development activities. Shenyang Xingqi Pharmaceutical Co.,Ltd. was founded in 1977 and is based in Shenyang, the People’s Republic of China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 2K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 2K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 1K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 634%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 545%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 525%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 30K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 21K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 14K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 13K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 11K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 11K%	20.5	Switzerland

chevron_leftBack